Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H26N2O2 |
Molecular Weight | 362.4647 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1CC[C@@](C2CCN(CC3=CC=CC=C3)CC2)(C(=O)N1)C4=CC=CC=C4
InChI
InChIKey=LQQIVYSCPWCSSD-HSZRJFAPSA-N
InChI=1S/C23H26N2O2/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18/h1-10,20H,11-17H2,(H,24,26,27)/t23-/m1/s1
Dexetimide is a potent central and peripheral anticholinergic agent. It has a high affinity for all subtypes of muscarinic receptor and a long duration action. It forms very stable complex with mAChR. Dexetimide was used for many years in Europe for the treatment of extrapyramidal disorders. Neuroleptic-induced parkinsonian symptoms are effectively controlled by dexetimide. It is a safe, potent, and long-acting antiparkinsonian agent.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent. | 1971 |
|
Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action. | 1973 Jul-Aug |
|
Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line. | 1998 Feb |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1020682
Dosages ranged from 0.5 to 1.5 mg daily
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QN04AA08
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
||
|
NCI_THESAURUS |
C29704
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
||
|
WHO-ATC |
N04AA08
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
D003909
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
CHEMBL1908364
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
354
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
DB08997
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
SUB07026MIG
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
30843
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
3267
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID701043218
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
831
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
m4217
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | Merck Index | ||
|
2726
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
100000083202
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
21888-98-2
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
43477QYX3D
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
C78069
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY | |||
|
Dexetimide
Created by
admin on Fri Dec 15 16:07:05 GMT 2023 , Edited by admin on Fri Dec 15 16:07:05 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)